Production and purification of refolded recombinant human IL-7 from inclusion bodies.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Protein Expression and Purification

• Publication date

  2003-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S1046-5928(03)00134-7PMID 12880763
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-7: master regulator of peripheral T-cell homeostasis?

  2001cited by this paper
• Comparative model building of interleukin‐7 using interleukin‐4 as a template: A structural hypothesis that displays atypical surface chemistry in helix D important for receptor activation

  2000cited by this paper
• Defective IL7R expression in T-B+NK + severe combined immunodeficiency

  1998cited by this paper
• Expansion of restricted cellular immune responses to HIV‐1 envelope by vaccination: IL‐7 and IL‐12 differentially augment cellular proliferative responses to HIV‐1

  1997cited by this paper
• Disulfide Bond Assignment in Human Interleukin-7 by Matrix-assisted Laser Desorption/Ionization Mass Spectroscopy and Site-directed Cysteine to Serine Mutational Analysis*

  1997cited by this paper
• Interleukin-7 induces anti-Mycobacterium avium activity in human monocyte-derived macrophages.

  1996cited by this paper
• Synergistic effects of IL-7 and IL-12 on human T cell activation.

  1995cited by this paper
• Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine

  1995cited by this paper
• Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy.

  1995cited by this paper
• The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15.

  1995cited by this paper
• Diverse immunological and hematological effects of interleukin 7: implications for clinical application

  1995cited by this paper
• Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes.

  1994cited by this paper
• Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo

  1994cited by this paper
• Administration of recombinant human IL-7 to mice alters the composition of B-lineage cells and T cell subsets, enhances T cell function, and induces regression of established metastases.

  1994cited by this paper
• Interleukin-7 selectively enhances natural kill cytotoxicity mediated by the CD56bright natural killer subpopulation.

  1994cited by this paper
• Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor.

  1993cited by this paper
• IL-2-independent activity of IL-7 in the generation of secondary antigen-specific cytotoxic T cell responses in vitro.

  1993cited by this paper
• Activation induced changes in expression and structure of the IL-7 receptor on human T cells.

  1992cited by this paper
• Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy

  1991cited by this paper
• Effects of IL-7 and IL-2 on highly enriched CD56+ natural killer cells. A comparative study.

  1991cited by this paper
• Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood

  1990cited by this paper
• Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily.

  1990cited by this paper
• Regulation of human cytotoxic T lymphocyte development by IL-7.

  1990cited by this paper
• Murine interleukin 7 (IL-7) receptor. Characterization on an IL-7- dependent cell line

  1990cited by this paper
• Interleukin 7 is a T-cell growth factor.

  1989cited by this paper
• Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells.

  1989cited by this paper
• B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors

  1988cited by this paper

• Implications of glycosylation for the development of selected cytokines and their derivatives for medical use

  2024cites this paper
• Soluble and insoluble expression of recombinant human interleukin-2 protein using pET expression vector in Escherichia coli

  2024influential citation
• Advances and applications of capillary electromigration methods in the analysis of therapeutic and diagnostic recombinant proteins - A Review.

  2022influential citation
• Quality comparison of recombinant soluble proteins and proteins solubilized from bacterial inclusion bodies.

  2022cites this paper
• Comparative Characteristics of Biotechnological Approaches to Obtaining Recombinant Human Cytokines in Bacterial Expressing Systems

  2019cites this paper
• Purification of New Biologicals Using Membrane-Based Processes

  2019cites this paper
• Host Cell Proteins During Biomanufacturing

  2019cites this paper
• Reassessment of inclusion body-based production as a versatile opportunity for difficult-to-express recombinant proteins

  2018cites this paper
• Recombinant chicken interleukin-7 as a potent adjuvant increases the immunogenicity and protection of inactivated infectious bursal disease vaccine

  2018cites this paper
• Title : Expression and Purification of Transmembrane Protein MerE from Mercury

  2017cites this paper
• Cloning and Expression of Recombinant Human Interleukin-7 in Chinese Hamster Ovary (CHO) Cells.

  2017cites this paper
• Purification of inclusion bodies using PEG precipitation under denaturing conditions to produce recombinant therapeutic proteins from Escherichia coli

  2017cites this paper
• A combinatorial approach of N-terminus blocking and codon optimization strategies to enhance the soluble expression of recombinant hIL-7 in E. coli fed-batch culture

  2016cites this paper
• Microbial Cell Factories for the Production of Recombinant Human Interferon Gamma

  2016cites this paper
• Comparison of the purification of biologically active IL-7 cytokine expressed in Escherichia coli and Pichia pastoris.

  2015cites this paper
• Purification, Characterization and Plasma Half-Life of PEGylated Soluble Recombinant Non-HA-Binding CD44

  2014cites this paper
• A baseline process for the production, recovery, and purification of bacterial influenza vaccine candidates

  2013influential citation
• Sweeping away protein aggregation with entropic bristles: intrinsically disordered protein fusions enhance soluble expression.

  2012cites this paper
• L-arginine mediated renaturation enhances yield of human, α6 Type IV collagen non-collagenous domain from bacterial inclusion bodies.

  2012cites this paper
• Increasing recombinant protein production in Escherichia coli through metabolic and genetic engineering

  2011cites this paper
• Protein Refolding/Renaturation

  2011cites this paper
• Expression of soluble proteins in Escherichia coli by linkage with the acidic propiece of eosinophil major basic protein.

  2011cites this paper
• Efficient preparation and PEGylation of recombinant human non-glycosylated erythropoietin expressed as inclusion body in E. coli.

  2010cites this paper
• Expression, purification, and functional characterization of recombinant human interleukin-7.

  2009cites this paper
• CZE for glycoform profiling and quality assessment of recombinant human interleukin‐7

  2009cites this paper
• Expression and purification of recombinant human hemangiopoietin in Escherichia coli

  2008cites this paper
• Expression and Production of Human Interleukin-7 in Insect Cells Using Baculovirus Expression Vector System (BEVS)

  2008cites this paper
• Prediction of Protein Solubility in Escherichia Coli Using Discriminant Analysis, Logistic Regression, and Artificial Neural Network Models

  2007cites this paper
• Production of recombinant proteins by high cell density culture of Escherichia coli

  2006cites this paper
• Folding of Aggregated Proteins to Functionally Active Form

  2006cites this paper
• Folding aggregated proteins into functionally active forms.

  2006cites this paper
• A novel protein refolding method using a zeolite.

  2006cites this paper
• Protein expression and refolding--a practical guide to getting the most out of inclusion bodies.

  2004cites this paper